Center for Research in Emerging Infectious Diseases: Epidemiology, Surveillance and Pathogenesis
Official title: Center for Research in Emerging Infectious Diseases - Epidemiology, Surveillance and Pathogenesis
Funded at Washington University · NIH-11632164 · Data updated 2026-11-12
A NIH program will study and monitor emerging viruses from the Midwest U.S. and three Asian sites to understand how they spread and affect people.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | May 11, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $58,460 |
| NIH project number | 3U01AI151810-06S5 |
| Project ID | NIH-11632164 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are individuals with respiratory illness or fever who reside in or travel to study regions, and individuals in close contact with animals or ticks.
✕Less likely to help
Healthy individuals without exposure to the study regions or vectors may derive no direct benefit.
What this research studies
This project will track viruses in ticks and animals near humans, collect samples, and study how those viruses spread between animals, ticks, and people. Researchers will combine field surveillance with laboratory analyses to map where viruses are found and how common they are in different regions. The goal is to identify emerging threats and how they move across continents, so public health can respond quickly. People living in areas with tick exposure or close contact with animals may be involved through surveillance and potential future studies.
Why it matters
Potential benefit: If successful, the project could improve early detection and prevention of emerging infectious diseases that affect people at home and abroad.
How similar studies have gone: Other programs have demonstrated the value of integrated global surveillance for emerging pathogens, though specific viruses and sites in this project are novel.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Wang, David — Washington University
- Study coordinator: Wang, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.